Aberrant expression of T-cell-associated markers CD4 and CD7 on B-cell chronic lymphocytic leukemia

American Journal of Hematology

Volumn 82, Issue 1, 2007, Pages 73-76

  Jani, Prashant ^a,b   Qi, Xiao Ying ^a,b   Chang, Hong ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

CLL; Fluorescence in situ hybridization (FISH); Immunophenotyping

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD4 ANTIGEN; CD7 ANTIGEN; CD79B ANTIGEN; FMC7 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; KAPPA ANTIGEN; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; CANCER DIAGNOSIS; CASE REPORT; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CHRONIC LYMPHATIC LEUKEMIA; CYTOGENETICS; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL; T LYMPHOCYTE; TRISOMY 12;

AGED; ANTIGENS, CD; ANTIGENS, CD4; ANTIGENS, CD7; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, LEUKEMIC; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GENE REARRANGEMENT, T-LYMPHOCYTE; GLYCOPROTEINS; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, B-CELL, CHRONIC; MALE; TUMOR MARKERS, BIOLOGICAL;

EID: 33845956997     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20747     Document Type: Article

References (18)

1. Chiorazzi N, Rai K. Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005;352:804-815.
2. Matutes E, Polliack A. Morphological and immunophenotypic features of chronic lymphocytic leukemia. Rev Clin Exp Haematol 2000;4:22-47.
3. Porwit A, Borgonovo L, Osby E, Lenkei R, Smith CI, Hammarstrom L. B-chronic lymphocytic leukemia with aberrant expression of CD8 antigen. Eur J Haematol 1987;39:311-317.
4. Mulligan SP, Dao LP, Francis SE, et al. B-cell chronic lymphocytic leukemia with CD8 expression: Report of 10 cases and immunohistochemical analysis of the CD8 antigen. Br J Haematol 1998;103:157-162.
5. Espinosa A, Bjork P, Magnussen K, Moen T, Sorum Y. Aberrant expression of CD8 antigen in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 2003;44:193-196.
6. Kampalath B, Barcos MP, Stewart C. Phenotypic heterogeneity of B cells in patients with chronic lymphocytic leukemia/small lymphocytic leukemia. Am J Clin Pathol 2003;119:824-832.
7. Chang H, Kamel-Reid S, Hussain N, Lipton J, Messner HA. T-cell large granular lymphocytic leukemia of donor origin occurring after allogeneic bone marrow transplantation of B-cell lymphoproliferative disorders. Am J Clin Pathol 2005;123:196-199.
8. Chang H, Wechalekar A, Li L, Reece D. Molecular cytogenetic abnormalities in patients with concurrent chronic lymphocytic leukemia and multiple myeloma shown by interphase fluorescence in situ hybridization: Evidence of distinct clonal origin. Cancer Genet Cytogenet 2004;148:44-48.
9. Inaba T, Shimazaki C, Sumikuma T, et al. Expression of T cell associated antigens in B-cell non-Hodgkin's lymphoma. Br J Haematol 2000;109:592-599.
10. Kaleem Z, White G, Zutter M. Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkins lymphomas. Am J Clin Pathol 2001;115:396-403.
11. Kume M, Suzuki R, Yatabe Y, et al. Somatic hypermutations in the VH segment of immunoglobulin genes of CD5-positive diffuse large B-cell lymphoma. Jpn J Cancer Res 1997;88:1087-1093.
12. Taniguchi M, Oka K, Hiasa A, et al. De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood 1998;91:1145-1151.
13. Ahmad E, Garcia D, Davis BH. Clinical utility of CD23 and FMC7 antigen coexistent expression in B-cell lymphoproliferative disorder subclassification. Cytometry 2002;50:1-7.
14. Shapiro JL, Miller ML, Pohlman B, Mascha E, Fishleder AJ. CD5 B-cell lymphoproliferative disorder presenting in blood and bone marrow: A clinicopathologic study of forty patients. Am J Clin Pathol 1999;111:477-487.
15. Fisher RI, Danhlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM. A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa associated lymphoid tissue and monocytoid B-cell subcategories): A Southwest Oncology Group Study. Blood 1995;85:1075-1082.
16. Dohner H, Stilgenbauer S, Banner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000;343:1910-1916.
17. Cuneo A, Bigoni R, Rigolin GM, et al. Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features. Blood 1999;93:1372-1380.
18. O'Malley DP, Vance GH, Orazi A. Chronic lymphocytic leukemia/small lymphocytic lymphoma with trisomy 12 and focal cyclin D1 expression: A potential diagnostic pitfall. Arch Path Lab Med 2005;192:92-95.